EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: The REVEAL EPC substudy

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 4, 2013, Pages 375-383

  Povsic, Thomas J ^a,b,c   Najjar, Samer S ^d,e   Prather, Kristi ^a   Zhou, Jiying ^b   Adams, Stacie D ^b   Zavodni, Katherine L ^b   Kelly, Francine ^b   Melton, Laura G ^a   Hasselblad, Vic ^a   Heitner, John F ^f   Raman, Subha V ^g   Barsness, Gregory W ^h   Patel, Manesh R ^a,b   Kim, Raymond J ^b   Lakatta, Edward G ^e   Harrington, Robert A ^a,b   Rao, Sunil V ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f NEW YORK METHODIST HOSPITAL   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h MAYO CLINIC   (United States)

Author keywords

Cryopreservation; Endothelial progenitor cells; Erythropoietin; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ALDEHYDE DEHYDROGENASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CELL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; PLACEBO;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BOLUS INJECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CD133+ T LYMPHOCYTE; CD34+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL SURFACE; CIRCULATION TIME; CONTROLLED STUDY; CRYOPRESERVATION; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; ENDOTHELIAL PROGENITOR CELL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEMATOCRIT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONONUCLEAR CELL; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL MOBILIZATION; T LYMPHOCYTE; TREND STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL CELLS; ERYTHROPOIETIN; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STEM CELLS;

EID: 84889093566     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0944-6     Document Type: Article

References (21)

1. Moon C, Krawczyk M, Paik D, Lakatta E, Talan M (2005) Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window. Cardiovasc Drugs Ther 19:243-250
2. Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO (2004) Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J 18:1031-1033
3. Bahlmann FH, de Groot K, Spandau J-M, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103:921-926
4. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340-1346
5. Westenbrink BD, Lipsic E, van der Meer P, van der Harst P, Oeseburg H, Du Marchie Sarvaas GJ, Koster J, Voors AA, van Veldhuisen DJ, van Gilst WH, Schoemaker RG (2007) Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28:2018-2027
6. Prunier F, Pfister O, Hadri L, Liang L, del Monte F, Liao R, Hajjar RJ (2007) Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am J Physiol Heart Circ Physiol 292:H522-H529
7. Melloni C, Rao SV, Povsic TJ, Melton L, Kim RJ, Kilaru R, Patel MR, Talan M, Ferrucci L, Longo DL, Lakatta EG, Najjar SS, Harrington RA (2010) Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial. Am Heart J 160:795-803
8. Najjar SS, Rao SV, Melloni C, Raman SV, Povsic TJ, Melton L, Barsness GW, Prather K, Heitner JF, Kilaru R, Gruberg L, Hasselblad V, Greenbaum AB, Patel M, Kim RJ, Talan M, Ferrucci L, Longo DL, Lakatta EG, Harrington RA (2011) Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA 305:1863-1872
9. Gentry T, Foster S, Winstead L, Deibert E, Fiordalisi M, Balber A (2007) Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 9:259-274
10. Povsic T, Zavodni K, Kelly F, Zhu S, Goldschmidt-Clermont P, Dong C, Peterson E (2007) Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50:2243-2248
11. Povsic T, Adams SD, Zavodni KL, Kelly F, Melton L, Rao S, Najjar S, Harrington R, Peterson E (2009) Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples. J Thromb Thrombolysis 28:259-265
12. Olson W, Smolkin M, Farris E, Fink R, Czarkowski A, Fink J, Chianese-Bullock K, Slingluff C (2011) Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function. J Transl Med 9:26
13. Grundmann F, Scheid C, Braun D, Zobel C, Reuter H, Schwinger R, Müller-Ehmsen J (2007) Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction. Clin Res Cardiol 96:621-627
14. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776-2779
15. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R, De Ferrari GM, Ferlini M, Goffredo L, Bertoletti A, Klersy C, Pecci A, Moratti R, Tavazzi L (2005) Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105:199-206
16. Paczkowska E, Larysz B, Rzeuski R, Karbicka A, Jałowiński R, Kornacewicz-Jach Z, Ratajczak MZ, Machaliński B (2005) Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Eur J Haematol 75:461-467
17. Wang Y, Johnsen HE, Mortensen S, Bindslev L, Ripa RS, Haack-Sorensen M, Jorgensen E, Fang W, Kastrup J (2006) Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 92:768-774
18. Wojakowski W, Tendera M, Michalowska A, Majka M, Kucia M, Maslankiewicz K, Wyderka R, Ochala A, Ratajczak MZ (2004) Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:3213-3220
19. Scheubel RJ, Zorn H, Silber R-E, Kuss O, Morawietz H, Holtz J, Simm A (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42:2073-2080
20. Leone AM, Rutella S, Bonanno G, Abbate A, Rebuzzi AG, Giovannini S, Lombardi M, Galiuto L, Liuzzo G, Andreotti F, Lanza GA, Contemi AM, Leone G, Crea F (2005) Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26:1196-1204
21. Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 44:991-1002